Patricia A. Escobar

1.4k citations

21 papers · 826 indexed · h-index 13

Chemical Health and Safety top 5%
Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 15
Health, Toxicology and Mutagenesis top 5%
- Effects and risks of endocrine disrupting chemicals 5
- Water Treatment and Disinfection 2
Small Animals top 5%
- Animal testing and alternatives 5
Pollution top 10%
- Pharmaceutical and Antibiotic Environmental Impacts 3
Plant Science
- Genetically Modified Organisms Research 6
- Pesticide Exposure and Toxicity 2
Molecular Biology
- DNA Repair Mechanisms 4

Co-authors: Brian Burlinson Yoshifumi Uno Marie Vasquez Günter Speit Andrew Collins Raymond R. Tice Madoka Nakajima Andreas Hartmann
Cited by: Chemical Health and Safety Cancer Research Health, Toxicology and Mutagenesis
Journals: Mutation Research/Genetic Toxicology and Environmental Mutagenesis (10 papers)Environmental and Molecular Mutagenesis (3 papers)Regulatory Toxicology and Pharmacology (3 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Patricia A. Escobar

21 papers receiving 797 citations

Peers

Countries citing papers authored by Patricia A. Escobar

Since Specialization

Citations

This map shows the geographic impact of Patricia A. Escobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia A. Escobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia A. Escobar more than expected).

Fields of papers citing papers by Patricia A. Escobar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia A. Escobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia A. Escobar. The network helps show where Patricia A. Escobar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patricia A. Escobar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patricia A. Escobar Line = papers co-authored together Patricia A. Escobar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	N-nitrosamine impurity risk assessment in pharmaceuticals: Utilizing In vivo mutation relative potency comparison to establish an acceptable intake for NTTP Regulatory Toxicology and Pharmacology ·Mark W. Powley,Zhanna Sobol,George E. Johnson,Robert W. Clark,D. I. Bugrov,Fārūq ʿUmar,Louise Hillenkamp,Mark D. Mowery,Patricia A. Escobar	2024	8
2	Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir Toxicological Sciences ·Patricia A. Escobar,Zhanna Sobol,Randy R. Miller,H. R. Wheelock,Sibel CAN,Lakshman Meena,Nagaraja Muniappa,Rosa I. Sánchez,Kerry T. Blanchard,Louise Hillenkamp,Rupesh P. Amin,Sean P. Troth	2024	5
3	Next Generation Sequencing Workshop at the Royal Society of Medicine (London, May 2022): how genomics is on the path to modernizing genetic toxicology Mutagenesis ·Xinsheng Zhang,曾小玲,Jesse J. Salk,Iñigo Martincorena,Robert R. Young,Jill E. Kucab,Charles C. Valentine,Carole L. Yauk,Patricia A. Escobar,Kristine L. Witt,Roland Frötschl,Simon H. Reed,A. E. Ashford	2023	3
4	Comparison of the transgenic rodent mutation assay, error corrected next generation duplex sequencing, and the alkaline comet assay to detect dose-related mutations following exposure to N-nitrosodiethylamine Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Joel P. Bercu,Shaofei Zhang,Zhanna Sobol,Patricia A. Escobar,David M. Cammisuli,Maik Schuler	2023	24
5	Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines Regulatory Toxicology and Pharmacology ·Alejandra Trejo‐Martin,Joel P. Bercu,E TAGLIAFERRO,Rachael E. Tennant,Robert Thomas,Kevin P. Cross,Andreas Czich,A Le Roy,John Nicolette,Joel Murray,D. Szvalov,Jooyeun Cha,Zhengang Sun,D. Thomas,Anthony Lynch,James Harvey,Susanne Glowienke,Laura Custer,Patricia A. Escobar	2022	31
6	A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies Toxicological Sciences ·J. Christopher Corton,Constance A. Mitchell,Scott S. Auerbach,Pierre R. Bushel,Heidrun Ellinger‐Ziegelbauer,Patricia A. Escobar,Roland Froetschl,Alison H. Harrill,Kamin J. Johnson,James E. Klaunig,Arun R. Pandiri,Alexei A. Podtelezhnikov,Julia E. Rager,Keith Q. Tanis,Jan Willem van der Laan,خليل شريف حسني,Carole L. Yauk,Syril Pettit,Frank D. Sistare	2022	15
7	Revisiting the bacterial mutagenicity assays: Report by a workgroup of the International Workshops on Genotoxicity Testing (IWGT) Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Rita Schoeny,Kevin P. Cross,David M. DeMarini,Rosalie K. Elespuru,Atsushi Hakura,Dan D. Levy,Richard V. Williams,Errol Zeiger,Patricia A. Escobar,Jonathan Howe,Masayuki Kato,Adedeji Charles Adeyemo,Martha M. Moore,Stéphanie Simon,Leon F. Stankowski,Kei‐ichi Sugiyama,Bas‐jan M. van der Leede	2020	6
8	Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective Regulatory Toxicology and Pharmacology ·Vincent L. Reynolds,Paul Butler,Ramón González Viramontes,Laura Aschenbrenner,Derek Best,N. Mourik,Meredith E. Crosby,Laura Custer,Patricia A. Escobar,Kyle L. Kolaja,Jonathan G. Moggs,Dana Shuey,Yuan Yun-hua,Terry Van Vleet,Chang Jiang,Timothy K. Hart	2020	1
9	Recommended criteria for the evaluation of bacterial mutagenicity data (Ames test) Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Dan D. Levy,Errol Zeiger,Patricia A. Escobar,Atsushi Hakura,Bas‐jan M. van der Leede,Masayuki Kato,Martha M. Moore,Kei‐ichi Sugiyama	2019	65
10	Analysis of historical negative control group data from the rat in vivo micronucleus assay Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·David P. Lovell,Mick D. Fellows,Levi Sharon,James Whitwell,Laura Custer,Stephen D. Dertinger,Patricia A. Escobar,Jantao,Ulrike Hemmann,Julia Kenny,Robert Smith,Bas‐jan M. van der Leede,Andreas Zeller	2019	2
11	Are all bacterial strains required by OECD mutagenicity test guideline TG471 needed? Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Richard V. Williams,David M. DeMarini,Leon F. Stankowski,Patricia A. Escobar,Errol Zeiger,Jonathan Howe,Rosalie K. Elespuru,Kevin P. Cross	2019	47
12	Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy Environmental and Molecular Mutagenesis ·Stephen D. Dertinger,Andrew R. Kraynak,Clothilde Mircher,Signorelli Michele,Steven M. Bryce,Nikki E. Hall,Jeffrey C. Bemis,Sheila M. Galloway,Patricia A. Escobar,George E. Johnson	2019	31
13	Demonstrating laboratory proficiency in bacterial mutagenicity assays for regulatory submission Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Dan D. Levy,Atsushi Hakura,Rosalie K. Elespuru,Patricia A. Escobar,Masayuki Kato,Adedeji Charles Adeyemo,Martha M. Moore,Kei‐ichi Sugiyama	2019	16
14	In Vivo Mutagenicity Testing of Arylboronic Acids and Esters Environmental and Molecular Mutagenesis ·Yelena Losev,Krista L. Dobo,Michelle Kenyon,Julia Kenny,Sheila M. Galloway,Patricia A. Escobar,M. Vijayaraj Reddy,Robert A. Jolly,Alejandra Trejo‐Martin,Jindian Zhou,Petra Bohner,M. B. Young,University of Kansas. Remote Sensing Laboratory,Kamala Pant,章河合,Rohan Kulkarni,Joel P. Bercu	2019	10
15	JaCVAM-organized international validation study of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens: I. Summary of pre-validation study results Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Yoshifumi Uno,Hajime Kojima,Takashi Omori,Raffaella Corvi,F. H. B.,Leonard M. Schechtman,Raymond R. Tice,Brian Burlinson,Patricia A. Escobar,Andrew R. Kraynak,Yuzuki Nakagawa,Madoka Nakajima,Kamala Pant,Norihide Asano,David Lovell,Takeshi Morita,Yasuo Ohno,Makoto Hayashi	2015	13
16	Critical issues with the in vivo comet assay: A report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT) Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Günter Speit,Hajime Kojima,Brian Burlinson,Andrew Collins,Peter Kasper,Ulla Plappert‐Helbig,Yoshifumi Uno,Marie Vasquez,Carol Beevers,Marlies De Boeck,Patricia A. Escobar,Sachiko Kitamoto,Kamala Pant,Stefan Pfuhler,Jin Tanaka,Dan D. Levy	2014	49
17	Bacterial mutagenicity screening in the pharmaceutical industry Mutation Research/Reviews in Mutation Research ·Patricia A. Escobar,Raymond A. Kemper,Nobuhiko NISHIWAKP,John Nicolette,Michelle Kenyon,Susanne Glowienke,Satin G. Sawant,TH. BOTHMANN,Timothy E. Johnson,Crystal McKnight,LV Shan-n,Sheila M. Galloway,Laura Custer,Elmar Gocke,Mike O’Donovan,Richard I. Fine,Ronald D. Snyder,Brinda Mahadevan	2012	49
18	Coupling cytotoxicity biomarkers with DNA damage assessment in TK6 human lymphoblast cells Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Jing Shi,Sandra A. Springer,Patricia A. Escobar	2010	20
19	Leukaemia-specific chromosome damage detected by comet with fluorescence in situ hybridization (comet-FISH) Mutagenesis ·Patricia A. Escobar,Martyn T. Smith,Mao‐Qiong Lin,Alan Hubbard,Brent A. Adler	2007	37
20	Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Brian Burlinson,Raymond R. Tice,Günter Speit,Eva Agurell,Susanne Brendler‐Schwaab,Andrew Collins,Patricia A. Escobar,Masamitsu Honma,T. S. Kumaravel,Madoka Nakajima,Yū F. Sasaki,Véronique Thybaud,Yoshifumi Uno,Marie Vasquez,Andreas Hartmann	2006	392

About Patricia A. Escobar

Patricia A. Escobar is a scholar working on Cancer Research, Small Animals and Health, Toxicology and Mutagenesis, having authored 21 papers that have together received 826 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (15 papers), Genetically Modified Organisms Research (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Animal testing and alternatives (5 papers), DNA Repair Mechanisms (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers), Pesticide Exposure and Toxicity (2 papers) and Water Treatment and Disinfection (2 papers). The work is most often cited by research in Chemical Health and Safety (25 citations), Cancer Research (473 citations) and Health, Toxicology and Mutagenesis (266 citations). Patricia A. Escobar has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Brian Burlinson, Yoshifumi Uno, Marie Vasquez, Günter Speit, Andrew Collins, Raymond R. Tice, Madoka Nakajima, Andreas Hartmann, Eva Agurell and Yū F. Sasaki. Their work appears in journals such as Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Environmental and Molecular Mutagenesis, Regulatory Toxicology and Pharmacology, Mutagenesis and Toxicological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact